LEGN Legend Biotech Corporation ADRs

Legend Biotech is a clinical stage biopharmaceutical company engaged in the discovery and development of novel cell therapies in hematology/oncology, infectious diseases and auto-immune disorders. Legend operates in the USA, mainland China and Ireland. This is an ADR of a company that does not have its stock publicly traded anywhere else in the world.

$30.52  +0.17 (0.56%)
As of 05/13/2021 11:48:24 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  ADRs
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  China
Country of incorporation:  
IPO date:  01/02/2015
Outstanding shares:  133,005,128
Average volume:  251,401
Market cap:   $3,902,370,456
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
CUSIP:    52490G102
ISIN:        US52490G1022
Sedol:      BMX9K07
Valuation   (See tab for details)
PE ratio:   -12.94
PB ratio:   14.01
PS ratio:   51.57
Return on equity:   -108.30%
Net income %:   -401.02%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy